These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37549505)

  • 21. Randomized, placebo controlled phase I trial of the safety, pharmacokinetics, pharmacodynamics and acceptability of a 90 day tenofovir plus levonorgestrel vaginal ring used continuously or cyclically in women: The CONRAD 138 study.
    Thurman AR; Brache V; Cochon L; Ouattara LA; Chandra N; Jacot T; Yousefieh N; Clark MR; Peet M; Hanif H; Schwartz JL; Ju S; Marzinke MA; Erikson DW; Parikh U; Herold BC; Fichorova RN; Tolley E; Doncel GF
    PLoS One; 2022; 17(10):e0275794. PubMed ID: 36215267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravaginal ring eluting tenofovir disoproxil fumarate completely protects macaques from multiple vaginal simian-HIV challenges.
    Smith JM; Rastogi R; Teller RS; Srinivasan P; Mesquita PM; Nagaraja U; McNicholl JM; Hendry RM; Dinh CT; Martin A; Herold BC; Kiser PF
    Proc Natl Acad Sci U S A; 2013 Oct; 110(40):16145-50. PubMed ID: 24043812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravaginal ring delivery of the reverse transcriptase inhibitor TMC 120 as an HIV microbicide.
    Woolfson AD; Malcolm RK; Morrow RJ; Toner CF; McCullagh SD
    Int J Pharm; 2006 Nov; 325(1-2):82-9. PubMed ID: 16884869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of polyether urethane intravaginal rings for the sustained delivery of hydroxychloroquine.
    Chen Y; Traore YL; Li A; Fowke KR; Ho EA
    Drug Des Devel Ther; 2014; 8():1801-15. PubMed ID: 25336923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fused deposition modeling three-dimensional printing of flexible polyurethane intravaginal rings with controlled tunable release profiles for multiple active drugs.
    Chen Y; Traore YL; Walker L; Yang S; Ho EA
    Drug Deliv Transl Res; 2022 Apr; 12(4):906-924. PubMed ID: 35211869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug delivery in multiple indication (multipurpose) prevention technologies: systems to prevent HIV-1 transmission and unintended pregnancies or HSV-2 transmission.
    Friend DR
    Expert Opin Drug Deliv; 2012 Apr; 9(4):417-27. PubMed ID: 22385316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An intravaginal ring for the sustained delivery of antibodies.
    Gunawardana M; Baum MM; Smith TJ; Moss JA
    J Pharm Sci; 2014 Nov; 103(11):3611-3620. PubMed ID: 25231193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-acting injectable multipurpose prevention technology for prevention of HIV and unplanned pregnancy.
    Young IC; Pallerla A; Cottrell ML; Maturavongsadit P; Prasher A; Shrivastava R; De la Cruz G; Montgomery SA; Schauer A; Sykes C; Kashuba ADM; Benhabbour SR
    J Control Release; 2023 Nov; 363():606-620. PubMed ID: 37797892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Mixed-Methods Study Examining Adherence to and Acceptability of Intravaginal Rings for HIV Prevention: Behavioral Results of MTN-027.
    Bauermeister JA; Golinkoff JM; Carballo-Diéguez A; Giguere R; López D; Hoesley CJ; Chen BA; Anderson P; Dezzutti CS; Strizki J; Sprinkle C; Heard F; Hall W; Jacobson C; Berthiaume J; Mayo A; Richardson BA; Piper J;
    AIDS Behav; 2020 Feb; 24(2):607-616. PubMed ID: 30877580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and pharmacokinetics of dapivirine delivery from matrix and reservoir intravaginal rings to HIV-negative women.
    Nel A; Smythe S; Young K; Malcolm K; McCoy C; Rosenberg Z; Romano J
    J Acquir Immune Defic Syndr; 2009 Aug; 51(4):416-23. PubMed ID: 19623693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An Intravaginal Ring for the Simultaneous Delivery of an HIV-1 Maturation Inhibitor and Reverse-Transcriptase Inhibitor for Prophylaxis of HIV Transmission.
    Ugaonkar SR; Clark JT; English LB; Johnson TJ; Buckheit KW; Bahde RJ; Appella DH; Buckheit RW; Kiser PF
    J Pharm Sci; 2015 Oct; 104(10):3426-39. PubMed ID: 26149293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An intravaginal ring for the simultaneous delivery of multiple drugs.
    Baum MM; Butkyavichene I; Gilman J; Kennedy S; Kopin E; Malone AM; Nguyen C; Smith TJ; Friend DR; Clark MR; Moss JA
    J Pharm Sci; 2012 Aug; 101(8):2833-43. PubMed ID: 22619076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genital microbiota of women using a 90 day tenofovir or tenofovir and levonorgestrel intravaginal ring in a placebo controlled randomized safety trial in Kenya.
    Dabee S; Mugo N; Mudhune V; McLellan-Lemal E; Peacock S; O'Connor S; Njoroge B; Nyagol B; Thurman AR; Ouma E; Ridzon R; Wiener J; Haugen HS; Gasper M; Feng C; Allen SA; Doncel GF; Jaspan HB; Heffron R;
    Sci Rep; 2022 Jul; 12(1):12040. PubMed ID: 35835755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preferred Product Attributes of Potential Multipurpose Prevention Technologies for Unintended Pregnancy and Sexually Transmitted Infections or HIV Among U.S. Women.
    Hynes JS; Sheth AN; Lathrop E; Sales JM; Haddad LB
    J Womens Health (Larchmt); 2019 May; 28(5):665-672. PubMed ID: 30615569
    [No Abstract]   [Full Text] [Related]  

  • 35. Acceptability of a Tenofovir Disoproxil Fumarate Intravaginal Ring for HIV Pre-Exposure Prophylaxis Among Sexually Active Women.
    Dobkin A; McWalters J; Barnett R; Ray LL; Espinoza L; McGinn AP; Atrio JM; Keller MJ
    Sex Transm Dis; 2020 Dec; 47(12):819-824. PubMed ID: 33186337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An intravaginal ring for the sustained delivery of tenofovir disoproxil fumarate.
    Baum MM; Butkyavichene I; Churchman SA; Lopez G; Miller CS; Smith TJ; Moss JA
    Int J Pharm; 2015 Nov; 495(1):579-587. PubMed ID: 26386138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of anastrozole effects, delivered by an intravaginal ring in cynomolgus monkeys.
    Rotgeri A; Korolainen H; Sundholm O; Schmitz H; Fuhrmann U; Prelle K; Sacher F
    Hum Reprod; 2015 Feb; 30(2):308-14. PubMed ID: 25432919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics and Tolerability of a Novel 17β-Estradiol and Progesterone Intravaginal Ring in Sheep.
    Weiss H; Martell B; Constantine GD; Davis SM; Vidal JD; Mayer PR; Doorbar M; Friend DR
    J Pharm Sci; 2019 Aug; 108(8):2677-2684. PubMed ID: 30959058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A phase 1 randomized placebo-controlled safety and pharmacokinetic trial of a tenofovir disoproxil fumarate vaginal ring.
    Keller MJ; Mesquita PM; Marzinke MA; Teller R; Espinoza L; Atrio JM; Lo Y; Frank B; Srinivasan S; Fredricks DN; Rabe L; Anderson PL; Hendrix CW; Kiser PF; Herold BC
    AIDS; 2016 Mar; 30(5):743-51. PubMed ID: 26605514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3D printed clotrimazole intravaginal ring for the treatment of recurrent vaginal candidiasis.
    Tiboni M; Campana R; Frangipani E; Casettari L
    Int J Pharm; 2021 Mar; 596():120290. PubMed ID: 33524521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.